HITLAB Partner Feetsee by Diabetis Receives 2022 Lithuanian-American Innovation Award

HITLAB • October 25, 2022

The Baltic-American Freedom Foundation (BAFF), the U.S. Embassy in Lithuania, and the Innovation Agency of Lithuania celebrate visionaries of Lithuania’s tech and entrepreneurial community and the cutting-edge technologies created in partnership with U.S. partners.  

This year, the first prize for the Lithuanian- American Innovation Award was presented to Diabetis JSC for developing Feetsee, a self-monitoring device for early identification of foot ulcers, which if left untreated can lead to amputation. 

Diabetis was recognized as the most innovative and impactful among the companies competing. The award was announced at an October 20th event held at the  Energetikos ir technikos muziejus | Energy and Technology Museum. 

These traditional Lithuanian American innovation awards were presented for the fourth time. The Lithuanian American Innovation Award – established by the Baltic-American Freedom Foundation, the United States Embassy in Lithuania and the Innovation Agency. The awards are granted to a Lithuanian individual, organization, university, or firm that has developed an innovation in collaboration with a U.S. partner. The award recognizes creative solutions and developments broadly across business and commerce, academic and scientific research, medicine and health, the environment, energy, and education. The founder of the monetary prizes is the Baltic-American Freedom Foundation. 
 

Click here for more information.